The Journal of Bone and Joint Surgery (American). 2005;87:503-507.
doi:10.2106/JBJS.D.01896
© 2005 The Journal of Bone and Joint Surgery, Inc.
Botulinum Toxin Injection in the Treatment of Tennis Elbow
A Double-Blind, Randomized, Controlled, Pilot Study
M.J. Hayton, FRCS(Tr and Orth)1,
A.J.A. Santini, FRCS(Tr and Orth)2,
P.J. Hughes, FRCS(Tr and Orth)3,
S.P. Frostick, MA, FRCS, DM2,
I.A. Trail, MD, FRCS1 and
J.K. Stanley, MCh(Orth), FRCS1
1 Wrightington Hospital, Hall Lane, Appley Bridge, Wigan WN6 9EP, United
Kingdom. E-mail address for M.J. Hayton:
mjhayton{at}aol.com
2 Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, United
Kingdom
3 Royal Preston Hospital, Sharoe Green Lane, Preston PR2 9HT, United
Kingdom
Investigation performed at Wrightington Hospital, Wigan, and Royal
Liverpool University Hospital, Liverpool, United Kingdom
The authors did not receive grants or outside funding in support of their
research or preparation of this manuscript. One or more of the authors
received payments or other benefits or a commitment or agreement to provide
such benefits from a commercial entity (the botulinum toxin was supplied by
Allergan). No commercial entity paid or directed, or agreed to pay or direct,
any benefits to any research fund, foundation, educational institution, or
other charitable or nonprofit organization with which the authors are
affiliated or associated.
Background: A recent report has suggested that local injection of
botulinum toxin type A is an effective method of treatment for chronic tennis
elbow. The toxin is thought to provide temporary paralysis of the painful
common extensor origin, thereby allowing a healing response to occur. To test
this theory, we performed a double-blind, randomized, controlled, pilot trial
comparing injections of botulinum toxin type A with those of a placebo (normal
saline solution) in the treatment of chronic tennis elbow.
Methods: Forty patients with a history of chronic tennis elbow for
which all conservative treatment measures, including steroid injection, had
failed were randomized into two groups. Half the patients received 50 units of
botulinum toxin type A, and the remainder received normal saline solution. The
intramuscular injections were performed 5 cm distal to the maximum point of
tenderness at the lateral epicondyle, in line with the middle of the wrist.
The two solutions used for the injections were identical in appearance and
temperature. The results of a quality-of-life assessment with the Short
Form-12 (SF-12), the pain score on a visual analogue scale, and the grip
strength measured with a validated Jamar dynamometer were recorded before and
three months after the injection.
Results: Three months following the injections, there was no
significant difference between the two groups with regard to grip strength,
pain, or quality of life.
Conclusions: With the numbers studied, we failed to find a
significant difference between the two groups; thus, we have no evidence of a
benefit from botulinum toxin injection in the treatment of chronic tennis
elbow.
Level of Evidence: Therapeutic Level II. See Instructions
to Authors for a complete description of levels of evidence.

CiteULike Connotea Del.icio.us Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. P. Calfee, A. Patel, M. F. DaSilva, and E. Akelman
Management of Lateral Epicondylitis: Current Concepts
J. Am. Acad. Ortho. Surg.,
January 1, 2008;
16(1):
19 - 29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cowan, S. Lozano-Calderon, and D. Ring
Quality of Prospective Controlled Randomized Trials. Analysis of Trials of Treatment for Lateral Epicondylitis as an Example
J. Bone Joint Surg. Am.,
August 1, 2007;
89(8):
1693 - 1699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Placzek, W. Drescher, G. Deuretzbacher, A. Hempfing, and A. L. Meiss
Treatment of Chronic Radial Epicondylitis with Botulinum Toxin A. A Double-Blind, Placebo-Controlled, Randomized Multicenter Study
J. Bone Joint Surg. Am.,
February 1, 2007;
89(2):
255 - 260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Gartsman and S. S. Hasan
What's New in Shoulder and Elbow Surgery
J. Bone Joint Surg. Am.,
January 1, 2006;
88(1):
230 - 243.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Wong, A. C.F. Hui, P.-Y. Tong, D. W.F. Poon, E. Yu, and L. K.S. Wong
Treatment of Lateral Epicondylitis with Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled Trial
Ann Intern Med,
December 6, 2005;
143(11):
793 - 797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Pullman
The Myriad Uses of Botulinum Toxin
Ann Intern Med,
December 6, 2005;
143(11):
838 - 839.
[Full Text]
[PDF]
|
 |
|
Letters to the Editor:
Read all Letters to the Editor
- Is Botulinum Toxin effective for treating Tennis Elbow?
- George Ampat, FRCS(Tr & Orth)
- JBJS Online, 26 May 2005
[Full text]
- MJ Hayton and colleagues respond to Mr. Ampat
- M.J. Hayton, FRCS(Tr and Orth), et al.
- JBJS Online, 26 May 2005
[Full text]
|